Cart
sales@molnova.com
AM-5308
CAS No. 2410796-89-1
AM-5308( —— )
Catalog No. M35734 CAS No. 2410796-89-1
AM-5308 is a kinesin KIF18A inhibitor that can be used to study cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 225 | Get Quote |
|
| 5MG | 353 | Get Quote |
|
| 10MG | 534 | Get Quote |
|
| 25MG | 1030 | Get Quote |
|
| 50MG | 1638 | Get Quote |
|
| 100MG | 2592 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAM-5308
-
NoteResearch use only, not for human use.
-
Brief DescriptionAM-5308 is a kinesin KIF18A inhibitor that can be used to study cancer.
-
DescriptionAM-5308 is a potent kinesin KIF18A inhibitor (WO2021211549A1, C13).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMicrotubule Associated
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2410796-89-1
-
Formula Weight529.65
-
Molecular FormulaC26H35N5O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (188.80 mM; Ultrasonic )
-
SMILESC(NC=1N=C(C=CC1)N2C[C@@H](C)OCC2)(=O)C3=C(N4CCC5(CC5)CC4)C=C(NS(CCO)(=O)=O)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Marc Noel PAYTON, et al. Kif18a inhibitors for treatment of neoplastic diseases. WO2021211549A1.
molnova catalog
related products
-
Pseudobufarenogin
Pseudobufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
-
Micronomicin
Micronomicin is an antibiotic exhibiting antibacterial and bactericidal capacity.
-
1-Methyl-2-[(6Z,9Z)-...
Methyl-2-[(6Z,9Z)-6,9-pentadecadienyl]-4(1H)-quinolone9, a quinolone alkaloid derived from Evodia rutaecarpa, is a potent antagonist of the angiotensin II receptor, displaying an IC50 value of 48.2 μM.
